Q4 2013 Holdings
Filed 2014-02-14 | 120 holdings | $639.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COM | 09062X103 | $306.2M | 1,095,100 | 47.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $198.6M | 3,760,900 | 31.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $99.5M | 1,414,100 | 15.6% |
| Cerus Corp(CERS) | COM | 157085101 | $21.8M | 3,375,000 | 3.4% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $3.7M | 1,895,000 | 0.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.4M | 135,000 | 0.5% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $374.9K | 4,992,600 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $296.9K | 1,757,100 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $290.5K | 5,465,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $286.9K | 2,515,300 | 0.0% |
| Relypsa Inc | COM | 759531106 | $248.5K | 9,941,549 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $206.0K | 4,069,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $203.3K | 738,800 | 0.0% |
| Medivation Inc | COM | 58501N101 | $199.3K | 3,123,500 | 0.0% |
| Mylan Inc | COM | 628530107 | $182.9K | 4,214,500 | 0.0% |
| HCA Holdings Inc(HCA) | COM | 40412C101 | $179.3K | 3,758,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $176.6K | 1,596,800 | 0.0% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $172.6K | 3,017,600 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $170.8K | 1,534,200 | 0.0% |
| Merck & Co Inc New(MRK) | COM | 58933Y105 | $127.5K | 2,547,000 | 0.0% |
| Actavis PLC | SHS | G0083B108 | $119.8K | 713,000 | 0.0% |
| Perrigo Co | COM | 714290103 | $118.6K | 773,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $118.5K | 1,734,934 | 0.0% |
| Intermune Inc | COM | 45884X103 | $113.4K | 7,697,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $108.8K | 3,553,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $107.2K | 2,888,500 | 0.0% |
| Impax Laboratories Inc | COM | 45256B101 | $106.5K | 4,237,600 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $102.3K | 724,000 | 0.0% |
| Express Scripts Hldg Co | COM | 30219G108 | $90.4K | 1,287,000 | 0.0% |
| Carefusion Corp | COM | 14170T101 | $86.5K | 2,171,500 | 0.0% |
| Allergan Inc | COM | 018490102 | $86.1K | 775,200 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $83.9K | 2,117,648 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $80.5K | 1,173,100 | 0.0% |
| Zimmer Hldgs Inc(ZBH) | COM | 98956P102 | $77.8K | 835,200 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $71.7K | 2,063,100 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $66.2K | 4,794,300 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $59.6K | 791,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $58.6K | 4,989,300 | 0.0% |
| Affymetrix Inc | COM | 00826T108 | $58.4K | 6,810,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $57.6K | 9,389,000 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $57.3K | 626,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $57.3K | 355,000 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $55.4K | 1,446,008 | 0.0% |
| Stryker Corp(SYK) | COM | 863667101 | $53.9K | 716,700 | 0.0% |
| ST Jude MED Inc | COM | 790849103 | $51.6K | 833,600 | 0.0% |
| Health NET Inc | COM | 42222G108 | $46.3K | 1,561,400 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $45.9K | 1,927,000 | 0.0% |
| Wellpoint Inc | COM | 94973V107 | $39.6K | 429,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $31.9K | 1,202,000 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $31.7K | 1,310,600 | 0.0% |